002105 信隆健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.7222.32020.84336.16727.470
总资产报酬率 ROA (%)0.3891.2029.01313.2389.502
投入资产回报率 ROIC (%)0.4991.55512.41119.51613.023

边际利润分析
销售毛利率 (%)16.72618.54723.49422.47721.776
营业利润率 (%)1.463-0.73912.35712.6599.933
息税前利润/营业总收入 (%)1.1671.91712.22414.37313.149
净利润/营业总收入 (%)1.3851.74611.37211.4519.575

收益指标分析
经营活动净收益/利润总额(%)107.362-10.86194.67698.04182.821
价值变动净收益/利润总额(%)-29.327-4.489-3.3732.1873.145
营业外收支净额/利润总额(%)3.787150.9715.7413.2077.582

偿债能力分析
流动比率 (X)1.7631.7021.7151.3711.264
速动比率 (X)1.4021.3481.3021.0080.960
资产负债率 (%)41.07141.98244.03758.65861.231
带息债务/全部投入资本 (%)26.83525.63631.92942.087--
股东权益/带息债务 (%)255.906271.465202.859129.667122.835
股东权益/负债合计 (%)132.462127.538114.08863.70658.219
利息保障倍数 (X)-3.2954.104-13.79311.1005.477

营运能力分析
应收账款周转天数 (天)85.841110.15999.46275.6370.000
存货周转天数 (天)81.305116.31595.17464.6920.000